Search research articles
Contact Us
Filters
Showing results (91-100 of 104) with videos related to
Page
of 11
Sort By:
The Lancet. Oncology
|
June 6, 2020
Response assessment in diffuse intrinsic pontine glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group
Tabitha M Cooney, Kenneth J Cohen, Carolina V Guimaraes, et al.
Journal of Neuro-Oncology
|
February 28, 2023
Outcomes of intraventricular 131-I-omburtamab and external beam radiotherapy in patients with recurrent medulloblastoma and ependymoma
Kathryn R Tringale, Suzanne L Wolden, Matthias Karajannis, et al.
The Lancet. Oncology
|
June 20, 2018
Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial
Mark M Souweidane, Kim Kramer, Neeta Pandit-Taskar, et al.
Pediatric Blood & Cancer
|
July 5, 2024
Ovarian function in female survivors of high-risk neuroblastoma
Lauren Jimenez-Kurlander, Amelia DeRosa, Caroline E Kostrzewa, et al.
Cancer Letters
|
June 25, 2005
Epidural compression in neuroblastoma: Diagnostic and therapeutic aspects
Bruno De Bernardi, Walentyna Balwierz, Joanna Bejent, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 14, 2019
Biodistribution and Dosimetry of Intraventricularly Administered <sup>124</sup>I-Omburtamab in Patients with Metastatic Leptomeningeal Tumors
Neeta Pandit-Taskar, Pat B Zanzonico, Kim Kramer, et al.
Neuro-Oncology
|
February 19, 2025
Phase 1 dose-escalation trial using convection-enhanced delivery (CED) of radio-immunotheranostic 124I-Omburtamab for diffuse intrinsic pontine glioma (DIPG)
Mark M Souweidane, Evan D Bander, Pat Zanzonico, et al.
Plos One
|
June 6, 2017
A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors
Oren J Becher, Nathan E Millard, Shakeel Modak, et al.
Neuro-Oncology
|
August 1, 2023
Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047)
Michelle Monje, Tabitha Cooney, John Glod, et al.
Pediatric Blood & Cancer
|
September 1, 2024
Craniospinal irradiation and/or intraventricular radioimmunotherapy after high-dose chemotherapy and autologous stem cell rescue in patients with CNS retinoblastoma-Safety and outcomes
Sameer Farouk Sait, Nancy A Kernan, Elizabeth Klein, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 104) with videos related to
Sort By:
Page
of 11
The Lancet. Oncology
|
June 6, 2020
Response assessment in diffuse intrinsic pontine glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group
Tabitha M Cooney, Kenneth J Cohen, Carolina V Guimaraes, et al.
Journal of Neuro-Oncology
|
February 28, 2023
Outcomes of intraventricular 131-I-omburtamab and external beam radiotherapy in patients with recurrent medulloblastoma and ependymoma
Kathryn R Tringale, Suzanne L Wolden, Matthias Karajannis, et al.
The Lancet. Oncology
|
June 20, 2018
Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial
Mark M Souweidane, Kim Kramer, Neeta Pandit-Taskar, et al.
Pediatric Blood & Cancer
|
July 5, 2024
Ovarian function in female survivors of high-risk neuroblastoma
Lauren Jimenez-Kurlander, Amelia DeRosa, Caroline E Kostrzewa, et al.
Cancer Letters
|
June 25, 2005
Epidural compression in neuroblastoma: Diagnostic and therapeutic aspects
Bruno De Bernardi, Walentyna Balwierz, Joanna Bejent, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 14, 2019
Biodistribution and Dosimetry of Intraventricularly Administered <sup>124</sup>I-Omburtamab in Patients with Metastatic Leptomeningeal Tumors
Neeta Pandit-Taskar, Pat B Zanzonico, Kim Kramer, et al.
Neuro-Oncology
|
February 19, 2025
Phase 1 dose-escalation trial using convection-enhanced delivery (CED) of radio-immunotheranostic 124I-Omburtamab for diffuse intrinsic pontine glioma (DIPG)
Mark M Souweidane, Evan D Bander, Pat Zanzonico, et al.
Plos One
|
June 6, 2017
A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors
Oren J Becher, Nathan E Millard, Shakeel Modak, et al.
Neuro-Oncology
|
August 1, 2023
Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047)
Michelle Monje, Tabitha Cooney, John Glod, et al.
Pediatric Blood & Cancer
|
September 1, 2024
Craniospinal irradiation and/or intraventricular radioimmunotherapy after high-dose chemotherapy and autologous stem cell rescue in patients with CNS retinoblastoma-Safety and outcomes
Sameer Farouk Sait, Nancy A Kernan, Elizabeth Klein, et al.
Page
of 11